Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Jul;79(1):44–47. doi: 10.1136/adc.79.1.44

Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis

J Murphy 1, K Laiho 1, A Jones 1, S Wootton 1
PMCID: PMC1717623  PMID: 9771251

Abstract

AIM—To examine the gastrointestinal handling and metabolic disposal of emulsified [1-13C]palmitic acid esterified into a triglyceride in nine healthy children and seven patients with cystic fibrosis on enzyme replacement treatment.
METHODS—After an overnight fast, each child was given 10 mg/kg body weight
 [1,1,1-13C]tripalmitin with a standardised test meal of low natural 13C abundance. The total enrichment of 13C was measured using isotope ratio mass spectrometry in stool collected for a period of up to five days and in breath samples collected over a 24 hour period.
RESULTS—The mean proportion of administered 13C label excreted in stool was 6% (range, 1-12.7%) in healthy children and 24.6% (range, 0-64%) in patients with cystic fibrosis. Healthy children excreted 31.3% of the administered label on their breath (range, 14.2-42.9%). Correcting the excretion of administered 13C label on the breath for differences in digestion and absorption in patients with cystic fibrosis increased the difference between individuals from 0-31.3% of administered dose (mean, 17.9%) to 0-49.1% of absorbed dose (mean, 23.2%) and was poorly related to the amount of 13C label in stool.
CONCLUSION—Measurements of breath 13CO2 do not consistently reflect the gastrointestinal handling of emulsified 13C labelled tripalmitin because of differences in digestion and absorption in cystic fibrosis. Further studies need to examine whether "breath tests" alone can predict with confidence the gastrointestinal handling of other 13C labelled triglycerides and fatty acids.



Full Text

The Full Text of this article is available as a PDF (94.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amarri S., Harding M., Coward W. A., Evans T. J., Weaver L. T. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child. 1997 Apr;76(4):349–351. doi: 10.1136/adc.76.4.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Caprilli R., Frieri G., Latella G., Vernia P., Santoro M. L. Faecal excretion of bicarbonate in ulcerative colitis. Digestion. 1986;35(3):136–142. doi: 10.1159/000199359. [DOI] [PubMed] [Google Scholar]
  3. Elia M., Fuller N. J., Murgatroyd P. R. Measurement of bicarbonate turnover in humans: applicability to estimation of energy expenditure. Am J Physiol. 1992 Oct;263(4 Pt 1):E676–E687. doi: 10.1152/ajpendo.1992.263.4.E676. [DOI] [PubMed] [Google Scholar]
  4. Emken E. A., Adlof R. O., Rohwedder W. K., Gulley R. M. Influence of linoleic acid on desaturation and uptake of deuterium-labeled palmitic and stearic acids in humans. Biochim Biophys Acta. 1993 Oct 13;1170(2):173–181. doi: 10.1016/0005-2760(93)90068-k. [DOI] [PubMed] [Google Scholar]
  5. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  6. Irving C. S., Wong W. W., Shulman R. J., Smith E. O., Klein P. D. [13C]bicarbonate kinetics in humans: intra- vs. interindividual variations. Am J Physiol. 1983 Aug;245(2):R190–R202. doi: 10.1152/ajpregu.1983.245.2.R190. [DOI] [PubMed] [Google Scholar]
  7. Jones P. J., Pencharz P. B., Clandinin M. T. Whole body oxidation of dietary fatty acids: implications for energy utilization. Am J Clin Nutr. 1985 Nov;42(5):769–777. doi: 10.1093/ajcn/42.5.769. [DOI] [PubMed] [Google Scholar]
  8. Kalivianakis M., Verkade H. J., Stellaard F., van der Were M., Elzinga H., Vonk R. J. The 13C-mixed triglyceride breath test in healthy adults: determinants of the 13CO2 response. Eur J Clin Invest. 1997 May;27(5):434–442. doi: 10.1046/j.1365-2362.1997.1310678.x. [DOI] [PubMed] [Google Scholar]
  9. McClean P., Harding M., Coward W. A., Green M. R., Weaver L. T. Measurement of fat digestion in early life using a stable isotope breath test. Arch Dis Child. 1993 Sep;69(3):366–370. doi: 10.1136/adc.69.3.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Murphy J. L., Jones A. E., Stolinski M., Wootton S. A. Gastrointestinal handling of [1-13C]palmitic acid in healthy controls and patients with cystic fibrosis. Arch Dis Child. 1997 May;76(5):425–427. doi: 10.1136/adc.76.5.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murphy J. L., Jones A., Brookes S., Wootton S. A. The gastrointestinal handling and metabolism of [1-13C]palmitic acid in healthy women. Lipids. 1995 Apr;30(4):291–298. doi: 10.1007/BF02536035. [DOI] [PubMed] [Google Scholar]
  12. Murphy J. L., Wootton S. A., Bond S. A., Jackson A. A. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child. 1991 Apr;66(4):495–500. doi: 10.1136/adc.66.4.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Smyth R. L., van Velzen D., Smyth A. R., Lloyd D. A., Heaf D. P. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 Jan 8;343(8889):85–86. doi: 10.1016/s0140-6736(94)90817-6. [DOI] [PubMed] [Google Scholar]
  14. Vantrappen G. R., Rutgeerts P. J., Ghoos Y. F., Hiele M. I. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology. 1989 Apr;96(4):1126–1134. doi: 10.1016/0016-5085(89)91632-6. [DOI] [PubMed] [Google Scholar]
  15. Watkins J. B., Klein P. D., Schoeller D. A., Kirschner B. S., Park R., Perman J. A. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology. 1982 May;82(5 Pt 1):911–917. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES